Freedom Capital issued rating reports on Amgen stock, which trades on the NASDAQ exchange.
7 reports, 2 independent
Updated Oct 18
Gone quiet
- Reports
- 7
- Developments
- 1
- Repetition
- 86%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Freedom Capital issued rating reports on Amgen stock, which trades on the NASDAQ exchange.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Amgen
American multinational biopharmaceutical company
-
Freedom Capital
company in the Czech Republic
-
Nasdaq
American fully electronic stock exchange
Related events
- Freedom Capital lowered Gentex's rating, while MarketBeat reported consensus ratings for the company, which is listed on Nasdaq.
- Novavax stock is trading on the Nasdaq electronic stock exchange, with company news and ratings being aggregated by MarketBeat.
- PepsiCo, Walmart, and Amgen are confirmed to be listed on the Nasdaq exchange.
- Freedom Capital upgraded Alphabet Inc.'s stock rating on October 31, 2026.
- NewGenIvf Group Limited began trading on the Nasdaq stock exchange.